問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
林育麟
下載
2018-01-15 - 2029-06-30
Condition/Disease
Test Drug
Participate Sites7Sites
Recruiting5Sites
2019-02-01 - 2024-08-14
Participate Sites6Sites
Recruiting6Sites
2019-05-01 - 2026-12-31
2019-01-01 - 2024-12-25
Recruiting7Sites
2018-07-30 - 2020-09-30
Division of Hematology & Oncology
2017-11-01 - 2021-12-31
Participate Sites2Sites
Recruiting2Sites
2019-06-01 - 2025-12-31
Participate Sites3Sites
Recruiting3Sites
2019-04-01 - 2027-11-30
Participate Sites9Sites
Recruiting9Sites
2018-08-01 - 2026-12-01
Recruiting8Sites
2015-12-10 - 2019-12-31
NON-SMALL CELL LUNG CANCER WHO HAVE BRAIN METASTASES
(1)Avastin; (2) Erlotinib
全部
